• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain

Pathfinder

Editor, Senior Moderator
Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain


Introduction

Patients with influenza A (H1N1)v infection have developed rapidly progressive lower respiratory tract disease resulting in respiratory failure. We describe the clinical and epidemiologic characteristics of the first 32 persons reported to be admitted to the intensive care unit (ICU) due to influenza A (H1N1)v infection in Spain.

Methods: We used medical chart reviews to collect data on ICU adult patients reported in a standardized form.

Influenza A (H1N1)v infection was confirmed in specimens using real-time reverse transcriptase-polymerase-chain-reaction (RT PCR) assay.

Results: Illness onset of the 32 patients occurred between June 23 and July 31, 2009. The median age was 36 years (IQR = 31 - 52).

Ten (31.2%) were obese, 2 (6.3%) pregnant and 16 (50%) had pre-existing medical complications. Twenty-nine (90.6%) had primary viral pneumonitis, 2 (6.3%) exacerbation of structural respiratory disease and 1 (3.1%) secondary bacterial pneumonia.

Twenty-four patients (75.0%) developed multiorgan dysfunction, 7 (21.9%) received renal replacement techniques and 24 (75.0%) required mechanical ventilation. Six patients died within 28 days, with two additional late deaths.

Oseltamivir administration delay ranged from 2 to 8 days after illness onset, 31.2% received high-dose (300mg/day), and treatment duration ranged from 5 to 10 days (mean 8.0 + 3.3).

Conclusions: Over a 5-week period, influenza A (H1N1)v infection led to ICU admission in 32 adult patients, with frequently observed severe hypoxemia and a relatively high case-fatality rate. Clinicians should be aware of pulmonary complications of influenza A (H1N1)v infection, particularly in pregnant and young obese but previously healthy persons.

Author: Jordi RelloAlejandro RodriguezPedro IbanezLorenzo SociasJavier CebrianAsuncion MarquesJose GuerreroSergio Ruiz-SantanaEnrique MarquezFrutos del Nogal-SaezFrancisco Alvarez-LermaSergio MartinezMiquel FerrerManuel AvellanasRosa GranadaEnrique Maravi


http://7thspace.com/headlines/31980...ure_caused_by_influenza_a_h1n1v_in_spain.html
 
Back
Top Bottom